Adherence to MHRA Guidelines for Valproate Prescribing in General Adult Psychiatry

Adherence to MHRA Guidelines for Valproate Prescribing in General Adult Psychiatry

Aims: Valproate is widely prescribed for psychiatric conditions, particularly bipolar disorder, but carries significant teratogenic risks. The Medicines and Healthcare products Regulatory Agency (MHRA) mandates strict prescribing guidelines, particularly for women of childbearing potential, to mitig...

Full description

Saved in:

Bibliographic Details
Main Author:	Muhammad Talha Farooq
Format:	Article
Language:	English
Published:	Cambridge University Press 2025-06-01
Series:	BJPsych Open
Online Access:	https://www.cambridge.org/core/product/identifier/S2056472425105863/type/journal_article
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Physician’s Adherence to Clinical Guidelines for in-Hospital Anticoagulant Prescribing
by: A. A. Chernov, et al.
Published: (2018-09-01)

Evaluating psychiatry journals’ adherence to informed consent guidelines for case reports
by: Ashley J. Tsang, et al.
Published: (2025-07-01)

Correction: Evaluating psychiatry journals’ adherence to informed consent guidelines for case reports
by: Ashley J. Tsang, et al.
Published: (2025-07-01)

New NICE Guidelines on Sodium Valproate (November 2023)
by: Amany Elbagoury, et al.
Published: (2025-06-01)

Re-Audit of Adherence to Antipsychotic Prescribing Guidelines in a Psychiatric Unit for Older Adult Females: Evaluating Improvements and Compliance Post-Interventions
by: Maria Moisan, et al.
Published: (2025-06-01)

Association of valproate use and hippocampal atrophy in idiopathic generalized epilepsy
by: Xiang Huang, et al.
Published: (2025-01-01)

Improving Valproate Prescribing Practices in Women of Childbearing Age: An Audit Cycle in a Psychiatric Inpatient Setting in Qatar
by: Ahmad Alater, et al.
Published: (2025-06-01)

Valproate Toxicity
by: J Gordon Millichap
Published: (1988-08-01)

EPILEPSY AT ADULTS: GENDER COMORBIDE DISORDERS, APPLICATION OF VALPROATES
by: P. N. Vlasov
Published: (2016-06-01)

Clinical Audit of Use of Clonazepam in General Adult Psychiatry Patients
by: Nizar El Ahmadie, et al.
Published: (2025-06-01)

Evaluation of prescribing patterns of sodium valproate in neurological disease patients: a quasi-experimental pretest–posttest design study
by: Rehab H. Werida, et al.
Published: (2025-03-01)

Psychiatry Trainees’ Views of Relational Prescribing: A Mixed Methods Scoping Activity
by: Haroula Konstantinidou, et al.
Published: (2025-06-01)

USE OF INJECTABLE VALPROATE FORMULATIONS IN STATUS EPILEPTICUS IN ADULTS AND CHILDREN
by: A. A. Kholin
Published: (2015-04-01)

Valproate Metabolites and Hyperammonemia
by: J Gordon Millichap
Published: (1992-07-01)

Valproate for Intractable Epilepsy
by: J Gordon Millichap
Published: (1992-03-01)

Valproate-induced thrombocytopenia
by: N. V. Izmozherova, et al.
Published: (2024-04-01)

Essential Psychiatry in General Practice /
Published: (2010)

Guidelines prescribed by general practitioners to patients with acute low back pain regarding ‘return to work’
by: Petronella A. Hough, et al.
Published: (2007-12-01)

Evaluation of Antidepressant Prescribing in Treatment-Resistant Depression: A Clinical Audit on Adherence to NICE Guidelines and Its Impact on Patient Outcomes
by: Sarah Mostafa, et al.
Published: (2025-06-01)

Valproate-induced Hyperammonemic Encephalopathy
by: Hsiao-Feng Chou, et al.
Published: (2008-10-01)

Phenobarbital and Valproate for Febrile Convulsions
by: J Gordon Millichap
Published: (1988-10-01)

Valproate and Carbamazepine Comparative Trial
by: J Gordon Millichap
Published: (1995-03-01)

Valproate-Induced Congenital Malformations
by: J Gordon Millichap
Published: (2005-07-01)

Valproate, Carnitine, and Lipid Metabolism
by: J Gordon Millichap
Published: (1990-06-01)

Cognitive Effects of Topiramate and Valproate
by: J Gordon Millichap
Published: (2003-06-01)

Valproate-Induced Pubertal Arrest
by: J Gordon Millichap
Published: (1992-08-01)

Clozapine Prescribing in the General Hospitals
by: Hanna Tee, et al.
Published: (2025-06-01)

Renal Tubular Dysfunction with Valproate and CBZ
by: J Gordon Millichap
Published: (1999-02-01)

Hereditary Susceptibility to Fetal Valproate Syndrome
by: J Gordon Millichap
Published: (2002-09-01)

Valproate, Learning Disorders, and Epileptiform EEG
by: J Gordon Millichap
Published: (2000-12-01)

Valproate Induced Obesity and Polycystic Ovaries
by: J Gordon Millichap
Published: (1996-06-01)

Carbamazepine Vs Valproate and Cognitive Function
by: J Gordon Millichap
Published: (1996-10-01)

Valproate-induced disorders of dopamine metabolism and the development of valproate-induced parkinsonism: a new perspective on prevention and diagnosis
by: N. A. Shnayder, et al.
Published: (2025-06-01)

Psychiatry in general practice. Melvin W. Thorner
by: Joy Arruda

Adventures of psychiatry in a general hospital: a tale of C-L psychiatry origins and resistance in Brazil
by: Juliano Victor Luna, et al.
Published: (2024-12-01)

Antipsychotic Prescribing in an Older Persons Crisis Team. Has Adherence to the Guidelines Improved Since the Implementation of a Care Pathway for Managing Behaviour That Challenges in Dementia?
by: Roxy Celyn Rees, et al.
Published: (2025-06-01)

Global variation in antibiotic prescribing guidelines and the implications for decreasing AMR in the future
by: Emmama Jamil, et al.
Published: (2025-08-01)

A Case of Valproate Induced Hyperammonemic Encephalopathy
by: Surjit Tarafdar, et al.
Published: (2011-01-01)

Evaluation of the antinociceptive potential of sodium valproate in mice
by: Lidia Cristina Chitac, et al.
Published: (2014-06-01)

Subcutaneous panniculitis as complication of valproate-induced pancreatitis
by: Michel Tawk, et al.
Published: (2025-01-01)